(NASDAQ: BMEA) Biomea Fusion's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 9.53%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.89%.
Biomea Fusion's earnings in 2025 is -$128,627,000.On average, 4 Wall Street analysts forecast BMEA's earnings for 2025 to be -$66,690,744, with the lowest BMEA earnings forecast at -$74,768,778, and the highest BMEA earnings forecast at -$54,855,485. On average, 4 Wall Street analysts forecast BMEA's earnings for 2026 to be -$63,497,103, with the lowest BMEA earnings forecast at -$101,069,353, and the highest BMEA earnings forecast at -$37,572,250.
In 2027, BMEA is forecast to generate -$67,378,316 in earnings, with the lowest earnings forecast at -$98,063,573 and the highest earnings forecast at -$23,670,518.